Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Oracle Corporation    ORCL

Delayed Quote. Delayed  - 07/26 10:00:45 pm
40.94 USD   -0.53%
09:07p ORACLE : Glens Falls Hospital, University of Pittsburgh Medical Cent..
05:57p APPROACHING DEA : Khang & Khang LLP Announces Securities Class Actio..
05:31p DEADLINE UPCOMI : Orcl)
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period May 201420152016201720182019
Sales38 30638 25337 05737 96139 02340 055
Operating income (EBITDA)18 71718 10516 65717 16218 17718 865
Operating profit (EBIT)18 10917 39315 78616 26317 04917 327
Pre-Tax Profit (EBT)13 704-----
Net income10 9559 9388 9019 43910 07311 565
P/E ratio17,719,719,418,316,614,0
EPS ( $ )2,382,212,072,252,482,94
Dividend per Share ( $ )0,480,510,600,580,610,59
Yield1,14%1,17%1,49%1,42%1,49%1,44%
Reference price ( $ )42.0243.4940.241.1641.1641.16
Announcement Date06/19/2014
08:01pm
06/17/2015
08:00pm
06/16/2016
08:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period May 201420152016201720182019
Debt------
Finance14 64412 41012 27011 84510 48313 454
Operating income (EBITDA)18 71718 10516 65717 16218 17718 865
Leverage
(Debt/EBITDA)
------
Capital Expenditure5801 3911 1891 1691 1971 273
Book Value Per Share (BVPS)10,5 $11,2 $11,5 $11,5 $11,8 $12,5 $
Cash Flow per Share3,24 $3,18 $3,15 $3,32 $3,43 $3,72 $
Announcement Date06/19/2014
08:01pm
06/17/2015
08:00pm
06/16/2016
08:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 169 692 M$ -
Entreprise Value (EV) 157 846 M$ 159 209 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 18,3x 16,6x
Capitalization / Revenue 4,47x 4,35x
EV / Revenue 4,16x 4,08x
EV / EBITDA 9,20x 8,76x
Yield (DPS / Price) 1,42% 1,49%
Price to book (Price / BVPS) 3,59x 3,49x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 42,8% 43,7%
operating Leverage (Delta EBIT / Delta Sales) 1,24x 1,73x
Net Margin (Net Profit / Revenue) 24,9% 25,8%
ROA (Net Profit / Asset) 12,1% 10,4%
ROE (Net Profit / Equities) 25,7% 22,9%
Rate of Dividend 25,9% 24,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / Sales   3,08% 3,07%
Cash Flow / Sales 36,0% 36,3%
Capital Intensity (Assets / Sales) 2,05x 2,48x
Financial Leverage (Net Debt / EBITDA) -0,69x -0,58x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend